Seeking unity, G7 meets amid escalating Ukraine, Middle East conflicts

*

Seeking unity, G7 meets amid escalating Ukraine, Middle East conflicts
Seeking unity, G7 meets amid escalating Ukraine, Middle East conflicts

Leaders begin talks on global economy, trade differences

*

G7 aims to agree joint statement on Israel-Iran conflict

*

Effort underway to put Ukraine back on Trump’s radar

By David Ljunggren, John Irish, Andreas Rinke

KANANASKIS, Alberta, – Leaders from the Group of Seven nations begin annual talks on Monday amid wars in Ukraine and the Middle East that add to global economic uncertainty, as host Canada tries to avoid a clash with U.S. President Donald Trump.

The G7 leaders from Britain, Canada, France, Germany, Italy, Japan and the U.S., along with the European Union, are convening in the resort of Kananaskis in the Canadian Rockies until Tuesday. But beyond the serene and picturesque mountain setting, they confront challenges. The first five months of Trump’s second term upended foreign policy on Ukraine, raised anxiety over his closer ties to Russia and resulted in tariffs on U.S. allies. With an escalating Israel-Iran conflict, which is spiking global oil prices, the summit in Canada is seen as a vital moment to try and restore a semblance of unity between democratic powerhouses.

“The most important goal will be for the world’s seven largest industrial nations to reach agreement and take action,” German Chancellor Friedrich Merz said before attending his first G7.

That will not be easy. After years of consensus, the traditional allies have scrambled to keep Trump engaged and maintain unity. Canada has abandoned any effort to adopt an all-encompassing comprehensive communique to avert a repeat of a 2018 summit in Quebec, when Trump instructed the U.S. delegation to withdraw its approval of the final communique after leaving.

Instead, Ottawa has sought to get consensus for a chair’s statement that summarizes the key discussions and six other pre-negotiated declarations on issues such as migration, artificial intelligence and forest fires.

Talks on Monday will centre around the economy, advancing trade deals, and China. Efforts to reach an agreement to lower the G7 price cap on Russian oil even if Trump decided to opt out have been complicated by the surge in oil prices since Israel launched strikes on Iran on June 12, two diplomatic sources said. The escalation between the two regional foes is on the agenda, with diplomatic sources saying they hope to achieve at least a joint statement to urge restraint and a return to diplomacy.

“We are united. Nobody wants to see Iran get a nuclear weapon and everyone wants discussions and negotiations to restart,” France’s President Emmanuel Macron told reporters in Greenland on Sunday before travelling to Canada.

He added that given Israel’s dependence on U.S. weapons and munitions, Washington had the capacity to restart negotiations.

Trump said on Sunday many calls and meetings were taking place to broker peace.

RUSSIAN ELEPHANT IN THE ROOM

Highlighting the unease among some of Washington’s allies, Trump spoke on Saturday with Russian President Vladimir Putin and suggested the Russian leader could play a mediation role.

Macron dismissed the idea, arguing that Moscow could not be a negotiator because it had started an illegal war against Ukraine.

A European diplomat said Trump’s suggestion showed that Russia, despite being kicked out of the group in 2014 after annexing Crimea, was very much on U.S. minds.

“In the eyes of the U.S., there’s no condemnation for Ukraine; no peace without Russia; and now even credit for its mediation role with Iran. For Europeans, this will be a really tough G7,” the diplomat said.

Ukraine’s President Volodymyr Zelenskiy and NATO Secretary General Mark Rutte will attend the summit on Tuesday. European officials said they hoped to use the meeting, and next week’s NATO summit, to convince Trump to toughen his stance on Putin.

“The G7 should have the objective for us to converge again, for Ukraine to get a ceasefire to lead to a robust and lasting peace, and in my view it’s a question of seeing whether President Trump is ready to put forward much tougher sanctions on Russia,” Macron said.

This article was generated from an automated news agency feed without modifications to text.

Source link

Visited 1 times, 1 visit(s) today

Related Article

Minnesota Rep. Melissa Hortman and Sen. John Hoffman.

How the attacks on two Minnesota lawmakers unfolded

Facebook Tweet Email Link It was about 3:35 a.m. Saturday when Brooklyn Park police approached the home of former Minnesota House Speaker Melissa Hortman. Instinct had led them there, spurred by a 911 call 90 minutes earlier from the daughter of state Sen. John Hoffman. A masked man had come to the door of their

Local walkers raise more than £20,000 for Parkinson’s UK

Local walkers raise more than £20,000 for Parkinson’s UK

363 walkers took part in their local Walk for Parkinson’s event at Mote Park in Maidstone, raising more than £20,000 for Parkinson’s UK. All the money raised will go towards the charity’s new Nurse Appeal, which is aiming to raise £9m to fund Parkinson’s nurses and other specialists. Parkinson’s specialists are a lifeline for the 153,000 people in the UK living

A person looking at a computer.

Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

Palantir Technologies (NASDAQ: PLTR) has emerged as a leading artificial intelligence company, offering AI data analytics to the U.S. government and businesses. And the company is growing quickly, with sales rising 39% to $884 million and adjusted earnings increasing 63% to $0.13 per share in the first quarter. That second figure is especially notable because

NXP Semiconductors’ (NASDAQ:NXPI) Dividend Will Be $1.01

NXP Semiconductors N.V. (NASDAQ:NXPI) will pay a dividend of $1.01 on the 9th of July. The dividend yield will be 1.9% based on this payment which is still above the industry average. Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit. If the

Sarepta and Roche halt DMD gene therapy’s use after second death  

Sarepta and Roche halt DMD gene therapy’s use after second death  

Elevidys is the only gene therapy approved in US for DMD. Dragon Claws via Shutterstock. Serepta and global partner Roche have discontinued the commercial and clinical use of Duchenne muscular dystrophy (DMD) gene therapy Elevidys (delandistrogene moxeparvovec) in non-ambulatory patients after a safety profile re-assessment following two patient deaths. Roche said that the dosing restrictions

0
Would love your thoughts, please comment.x
()
x